The Cervavac vaccine is a quadrivalent vaccine that targets four HPV subtypes — 6, 11, 16, and 18, and was compared with the Gardasil vaccine which contains the same four HPV subtypes.

The study, conducted among 9 to 15-year-old girls and boys, has shown that Cervavac is both safe and immunogenic, eliciting a robust immune response comparable to Merck’s widely used Gardasil ...

Gardasil-9 protects against nine HPV strains while Cervavac protects against four strains. But Cervavac is cost-effective and reliable. CERVAVAC, the Serum Institute’s made-in-India cervical ...

As of right now, India has access to two other vaccines that are licensed worldwide–Cervarix, marketed by GlaxoSmithKline, and Gardasil, marketed by Merck, apart from Cervavac. “Having an ...

Three main vaccines are currently available: Gardasil, Cervarix, and Cervavac. Gardasil, a quadrivalent vaccine, protects against HPV types 6, 11, 16, and 18, and costs approximately Rs 9,000 for ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.

Pause on Gardasil China sales from Feb to at least mid-2025 Keytruda beats, Gardasil misses Q4 sales estimates Merck pulls Gardasil's long-term sales target Shares tumble 11% in early trading Feb ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...